To understand the focus of startup Insamo Inc., one need look no further than its name, which co-founder and CEO Timothy Craven described as “portmanteau of ‘internally satisfied molecules,’” highlighting its efforts to create orally administered and membrane-permeable cyclic peptides across a range of disease areas.
Nascent Biotech, Inc. (OTCMKTS:NBIO – Get Free Report) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.16 and traded as low as $0.11. Nascent Biotech shares last traded at $0.12, with a volume of 10,100 shares trading hands. Nascent Biotech Trading […]
Nascent Biotech, Inc. (OTCMKTS:NBIO – Get Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.16 and traded as low as $0.11. Nascent Biotech shares last traded at $0.12, with a volume of 10,100 shares changing hands. Nascent Biotech Stock Performance […]
"Ascendis Pharma partners with Frazier Life Sciences, RA Capital Management, venBio, and HealthQuest Capital to launch ophthalmology company Eyconis. Eyconis wi
Nascent Biotech, Inc. (OTCMKTS:NBIO – Get Rating) passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.06 and traded as low as $0.05. Nascent Biotech shares last traded at $0.05, with a volume of 358,825 shares changing hands. Nascent Biotech Price Performance The […]